Aleksey Krylov

 Venture Capital, Fundraising and Crowdfunding / Posted 2 months ago

With a rich background as a Chief Financial Officer (CFO), Aleksey Krylov is a seasoned professional with in-depth expertise in the dynamic arenas of life sciences and medical technology. Aleksey presents a remarkable portfolio of over 70 successful fundraising and M&A transactions, showcasing his adeptness in steering companies through diverse strategic opportunities.

 

Holding an MBA from Columbia Business School and a Bachelor of Science in Business Administration from Babson College, Aleksey’s financial acumen is further illuminated in his transformative role as the CFO of CytoImmune Therapeutics where he secured over $100 million in funding.

 

As the CFO of DIH International, Aleksey Krylov strategically positioned the Swiss-Chinese medical equipment manufacturer for a NASDAQ public offering, emphasizing growth optimization and maximizing shareholder value. At SELLAS Life Sciences, he led a successful reverse merger, propelling the company to a market capitalization of several hundred million dollars. He also took care of investments of over $500 million across diverse industries as a family office investment professional.

 

Aleksey Krylov considers himself fortunate for his career success and entrepreneurial ventures. Driven by a desire to give back, he seeks to share ideas and thoughts that could benefit fellow entrepreneurs on their journeys. Aleksey Krylov’s impressive track record as a CFO not only witnesses his financial prowess but also proves his strong commitment to fostering growth and innovation in the business world.

Contact details

100 Church Street 8th floor New YorkUnited States,10007 ***** https://alekseykrylov.com/

Contact this listing owner

Please, login to contact this listing owner.

Linkedin

About Aleksey Krylov

With a rich background as a Chief Financial Officer (CFO), Aleksey Krylov is a seasoned professional with in-depth expertise in the dynamic arenas of life sciences and medical technology. Aleksey presents a remarkable portfolio of over 70 successful fundraising and M&A transactions, showcasing his adeptness in steering companies through diverse strategic opportunities. Holding an MBA from Columbia Business School and a Bachelor of Science in Business Administration from Babson College, Aleksey's financial acumen is further illuminated in his transformative role as the CFO of CytoImmune Therapeutics where he secured over $100 million in funding. As the CFO of DIH International, Aleksey strategically positioned the Swiss-Chinese medical equipment manufacturer for a NASDAQ public offering, emphasizing growth optimization and maximizing shareholder value. At SELLAS Life Sciences, he led a successful reverse merger, propelling the company to a market capitalization of several hundred million dollars. He also took care of investments of over $500 million across diverse industries as a family office investment professional. Aleksey considers himself fortunate for his career success and entrepreneurial ventures. Driven by a desire to give back, he seeks to share ideas and thoughts that could benefit fellow entrepreneurs on their journeys. Aleksey Krylov’s impressive track record as a CFO not only witnesses his financial prowess but also proves his strong commitment to fostering growth and innovation in the business world.

View all posts by Aleksey Krylov →